Records containing: Rheumatoid Arthritis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-09-10A Double-Blind, Placebo-Controlled, Parallel, Randomized Study to Evaluate the Efficacy and Safety of 3 Oral Dose Levels of TMI-005 in Subjects With Active Rheumatoid Arthritis on a Background of Methotrexate
-
CLINICAL_TRIALS study record update · 2009-09-03A Randomized, Placebo-Controlled, Multicenter, Blinded Phase I/II Study of the Safety of Escalating Doses of Ocrelizumab (PRO70769) in Subjects With Moderate to Severe Rheumatoid Arthritis Receiving Stable Doses of Concomitant Methotrexate
-
CLINICAL_TRIALS study record update · 2009-08-26Sensitivity of Echography in Arthritis
-
CLINICAL_TRIALS study record update · 2009-08-25An Exploratory, Open Label Pharmacokinetic - Pharmacodynamic Study to Compare Subcutaneous Versus Intravenous Administration of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2009-08-21A Phase II, Randomised, Double-blind, International, Multicentre, Placebo-controlled, Dose-ranging, Parallel-group Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Stable Methotrexate
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2009-08-21A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients
-
CLINICAL_TRIALS study record update · 2009-08-18Randomised, Multicenter, Open-label, Parallel-group Study Comparing Adalimumab 40 mg s.c. Eow Versus Infliximab 3 mg/kg i.v. Every 6 Weeks in Rheumatoid Arthritis Patients With Unsustainable Clinical Response to Infliximab 3 mg/kg Every 8 Weeks
-
CLINICAL_TRIALS study record update · 2009-07-23ClinicalTrials.gov study NCT00944320
-
CLINICAL_TRIALS study record update · 2009-07-23ClinicalTrials.gov study NCT00944255
-
CLINICAL_TRIALS study record update · 2009-07-16A Single-centre, Double-blind, Double-dummy, Randomised, Placebo-controlled, Four-period Crossover Study to Assess the Effect of Single Oral Doses of AZD5672 (600 mg and 150 mg) on QT/QTc Interval, Compared to Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2009-07-13A Multicenter, Randomized, Double-blind, Placebo-controlledTrial of Golimumab, a Fully Human Anti-TNFa MonoclonalAntibody, Administered Subcutaneously, in Methotrexate-naive Subjects With Active Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2009-07-07A Randomized Data Collection of the Maxim® Knee System With Removable Molded Polyethylene Tibia and the Regular Maxim® Knee System
-
CLINICAL_TRIALS study record update · 2009-07-07A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel-Group, 12-Week Study to Assess the Clinically Effective Dose Range of Etoricoxib and to Assess Its Safety and Tolerability in Patients With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2009-06-30An Open-Label, Randomized, 4 Period Crossover, Replicate Study to Assess the Relative Bioavailability of the Phase III and Phase IIb Formulations of AZD5672 in Healthy Male and Female Subjects
-
CLINICAL_TRIALS study record update · 2009-06-09A Phase 1, Randomized, 4-Period, 4-Sequence Cross-Over Study Of The Pharmacokinetics Of 3 Durations Of Release Of A Controlled Release Formulation And A Single Dose Of An Immediate Release Oral Suspension Of CE-224,535 In Normal Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2009-06-04Long-Term Safety Study of Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain
-
CLINICAL_TRIALS study record update · 2009-06-02A Phase II, Multicenter, Double-blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Intravenous Natalizumab (300 mg) in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Receiving Concomitant Treatment With Methotrexate (MTX)
-
CLINICAL_TRIALS study record update · 2009-06-01Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab-therapy
-
CLINICAL_TRIALS study record update · 2009-05-25A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Retreatment With Rituximab in Subjects With Rheumatoid Arthritis Receiving Background Methotrexate
-
CLINICAL_TRIALS study record update · 2009-04-20A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Dose Ranging Study to Evaluate Up to Three Doses of R935788 in Rheumatoid Arthritis Patients Failing to Respond to Methotrexate
-
CLINICAL_TRIALS study record update · 2009-04-15Clinical and Therapeutic Management of the Rheumatoid Arthritis in Spain
-
CLINICAL_TRIALS study record update · 2009-04-09An Open-Label, Phase I Study to Assess the Excretion of Radioactivity, Metabolic Profiles and Pharmacokinetics Following a Single Oral Dose of [14C]AZD5672 in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2009-03-16Study on the Quality of Sleep in Patients With Rheumatoid Arthritis
-
CLINICAL_TRIALS study record update · 2009-03-06Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety of Extended Treatment With Pegsunercept (PEG sTNF-RI) in Subjects With Rheumatoid Arthritis (RA)
-
CLINICAL_TRIALS study record update · 2009-03-03One Centre Follow-up Study on Safety and Efficacy